Sono-guided Oxygen-ozone and corticosteroid therapy for the treatment of musculoskeletal Pain in physical and rehabilitation medicine: Interventional pain management for Carpal tunnel syndrom: A prospective, randomized, double-blind, Multicente
The effect of topical corticosteroid and ozone injection under ultrasound guidance in the treatment of carpal tunnel syndrome
Design
A phase 3, umulticenteral, randomized, positive controlled, double blinded, clinical trial with a parallel group design of 50 patients, followed up one week and two months after injection
Settings and conduct
Department of Physical Medicine and Rehabilitation of Shohada Hospital and Imam Reza Hospital affiliated to Tabriz University of Medical Sciences and Physiotherapy and Rehabilitation Physics Department of Rasoul Akram Medical Center affiliated to Iran University of Medical Sciences
Participants/Inclusion and exclusion criteria
Having moderate or Severe moderate carpal tunnel syndrome confirmed by Electrodiagnosis (EDX) criteria, Unwillingness to undergo surgery; The presence of symptoms of severe atrophy or severe CTS in EMG-NCV, Contraindications for corticosteroid injection, Treatment of CTS with surgery or corticosteroid injection in the last 6 months, Traumatic or neoplastic origin of symptoms, Not having satisfaction for injection.
Tabriz University of Medical Sciences and Iran University of Medical Sciences
Expected recruitment start date
2017-08-23, 1396/06/01
Expected recruitment end date
2019-06-22, 1398/04/01
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Sono-guided Oxygen-ozone and corticosteroid therapy for the treatment of musculoskeletal Pain in physical and rehabilitation medicine: Interventional pain management for Carpal tunnel syndrom: A prospective, randomized, double-blind, Multicente
Public title
The effect of Oxygen-ozone and corticosteroid therapy for the treatment of Carpal tunnel syndrom
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Cavernous carpal tunnel syndrome confirmed by Electrodiogenesis (EDX) criteria
Severe moderate carpal tunnel syndrome that is proven by EDX criteria
The presence of paresthesia or numbness in the median nerve pathway
Unwillingness of the patient to undergo surgery
SNAP amplitude decrease
NCV across wrist smaller than 40 m/sec
Peak SNAP latency larger than 3.6 msec
CMAP latency larger than 4.2 msec
Exclusion criteria:
The presence of severe atrophic symptoms or severe CTS in EMG-NCV.
Contraindications for corticosteroid injection such as corticosteroid allergy and injection site infections
CTS treatment with surgery or corticosteroid injection in the last 6 months
Traumatic or neoplastic origin of symptoms
Not having satisfaction for injection
CMAP amplitude absence (CMAP) or the presence of symptoms of fib / psw in tense muscles
Signs of Cervical Activated Radiculopathy in Nidal Electromigraphy or Extruded Cervical Discs in MRI
Age
No age limit
Gender
Both
Phase
3
Groups that have been masked
Participant
Outcome assessor
Data analyser
Sample size
Target sample size:
50
Randomization (investigator's opinion)
Randomized
Randomization description
A simple random method for randomization will be used and individuals (patients) will form random units. A random sequence will be generated using RAS software. A central randomization method will be used to conceal random allocation. The random sequence will be created by the statistician and will be available to her. The doctor will be connected to the statistician by telephone or text message and will ask him or her about the random allocation of the participant to the specific group.
Blinding (investigator's opinion)
Double blinded
Blinding description
This randomized, double-blind randomized clinical trial is a multi-centered patient with a positive control group and will be performed in four groups of patients with musculoskeletal disorders by four physicians and physicians in four different health centers. All patients will be given enough information about the properties of ozone and corticosteroid injections, possible side effects, method and duration of testing, and the likelihood of having a candidate from one of the two treatments. All patients will be asked to sign a written informed consent form.In order to blind the patient, the doctor will prepare the injection material in the syringe, and will cover the syringes with an aluminum sheet to avoid being aware of the type of injection. It should be noted that dilution of corticosteroid and normal salon will be done to equalize the volume of all three injectable solutions.
Patients in each group will be evaluated by a physical medicine and rehabilitation specialist who is not aware of the type of injection, before the injection, one week after the injection and two months after the injection, and the rate of change between the two groups will be compared at different times. It should be noted that in each center all injections are performed by a constant person (a physical medicine and rehabilitation specialist).
Using three-flood coded questionnaires, where the first flood represents the group, the second flood indicates the time of the measurement of the outcome and the third flood represents the patient's code, the analyst will also be unaware of the allocation of people to the treatment groups.
Placebo
Not used
Assignment
Parallel
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Iran University of Medical Sciences
Street address
Hemmat Highway next to Milad Tower
City
Tehran
Province
Tehran
Postal code
۱۴۴۹۶۱۴۵۳۵
Approval date
2017-07-08, 1396/04/17
Ethics committee reference number
IR.IUMS.REC.1396.30324
Health conditions studied
1
Description of health condition studied
carpal tunnel syndrome
ICD-10 code
G59
ICD-10 code description
Mononeuropathy in diseases classified elsewhere
Primary outcomes
1
Description
Pain score based on Visual Analogue Scale
Timepoint
Before injection, 2 weeks and 8 weeks after injection
Method of measurement
Visual Analogue Scale
2
Description
The functional limitations and symptoms severity scales on Boston Questionnaire
Timepoint
Before injection, 2 weeks and 8 weeks after injection
Method of measurement
Boston Questionnaire
Secondary outcomes
1
Description
Clinical Global Impression
Timepoint
Before injection, 1 weeks and 8 weeks after injection
Method of measurement
Clinical Global Impression Questionnaire
2
Description
Patient Global Impression of Improvement
Timepoint
Before injection, 1 weeks and 8 weeks after injection
Method of measurement
Patient Global Impression of Improvement Questionnaire
3
Description
Electromyographic findings
Timepoint
Before injection, 1 weeks and 8 weeks after injection
Method of measurement
Nerve strip
4
Description
Median nerve cross section
Timepoint
Before injection, 1 weeks and 8 weeks after injection
Method of measurement
sonography
5
Description
Channel depth
Timepoint
Before injection, 1 weeks and 8 weeks after injection
Method of measurement
sonography
6
Description
Flexor Retinaculum Thickness
Timepoint
Before injection, 1 weeks and 8 weeks after injection
Method of measurement
sonography
Intervention groups
1
Description
Intervention group: 2cc ozone 20μg / L, around the median nerve with Medial approach as in-plane under ultrasound guidance.
Category
Treatment - Drugs
2
Description
Control group (corticosteroid therapy ): 1cc triamcinolone 40mg + 1cc normal slain, around the median nerve with Medial approach as in-plane under ultrasound guidance.
Category
Treatment - Drugs
Recruitment centers
1
Recruitment center
Name of recruitment center
Imam Reza Medical Research and Training Hospital,Tabriz University of Medical Sciences
Full name of responsible person
Dr. Bina Eftekharsaadat
Street address
Imam Reza Hospital
City
Tabriz
Province
East Azarbaijan
Postal code
5166614756
Phone
+98 21 3336 3161
Email
binasadat@yahoo.com
2
Recruitment center
Name of recruitment center
Shohada Medical Research and Training Hospital,Tabriz University of Medical Sciences
Full name of responsible person
Dr. Babak Kolahi
Street address
Imam Reza Esfahan University of Medical Sciences
City
Tabriz
Province
East Azarbaijan
Postal code
5166614756
Phone
+98 41 3336 3161
Email
dr.kolahi@gmail.com
3
Recruitment center
Name of recruitment center
Rasool Akram Hospital, Iran University of Medical Science